Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Mandala JP, Ahmad S, Pullagurla A, et al
Presented for research literature review only Lee E et al
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study
During your consultation, your provider will help you determine whether injectable or oral medications are the best option based on your health history, goals, and lifestyle preferences
Kamphorst, J
US$ 23.15
US$ 29.37
US$ 28.48
US$ 26.41
